insurance
CTNJ: COVID Response Offers Opportunities for Connecticut’s Future Healthcare System
The pandemic has been tragic in both lives lost and economic damage, especially to low wage workers. Our already flawed healthcare system has been seriously disrupted. Insurer profits are up, hospitals are losing money, and Connecticut healthcare jobs in April were down 28,400 from the year before. As the pandemic winds down, the recovery offers…
Read MoreFact Check: Do lower Medicaid provider payment rates cause higher commercial payment rates?
Download this Fact Check There’s a pervasive myth that lower Medicaid provider payment rates force providers to charge private insurers more to cover costs, but there is no evidence of that. On a simple level it makes some sense, but the truth is that providers, like most businesses, charge what they can, regardless of what…
Read MoreHelp for CT’s uninsured
With the recent spike in unemployment, many more Connecticut residents will be joining the thousands that were uninsured pre-COVID looking for healthcare coverage. The state has some new options to help. Check AccessHealthCT. You may be surprised to find that you qualify for HUSKY which is comprehensive, free, and includes most Connecticut providers. You may…
Read MoreCost Cap project could reduce access to care, stifle efficiency and innovation, and increase disparities
Download the Summary or Full Report Healthcare costs a lot in Connecticut, especially for middle and lower income residents. Primary care is the foundation of a healthy health system. Lowering costs and supporting primary care are important goals, however the Office of Health Strategy’s (OHS) new plan to limit costs is ill-conceived and likely to…
Read MoreAdvocates, providers send Governor, legislators letter about cost cap impact and unintended consequences
Yesterday, twenty advocates and providers sent letters to the Governor and legislative leaders objecting to the rush to develop a cap on healthcare cost increases during a pandemic, and to use the time to incorporate input from diverse stakeholders and for thoughtful design with a broad group chosen democratically. “This controversial proposal, if rushed ahead…
Read MoreCT Medical Society signs on with state HIE that plans to sell medical records
The state’s controversial HIE signed up its first participating provider network. Thursday the Office of Health Strategy (OHS) announced that CT Health Link, run by the CT State Medical Society (CSMS), will “immediately begin the technical connections necessary” to allow access into their system. Advocates have been concerned about OHS’s plans to sell access to…
Read MoreCOVID hits hospital bottom lines but boosts insurer profits
Contrary to earlier concerns, it appears that health insurers are doing pretty well through the COVID pandemic. It appears the costs of treating people with the virus are more than offset by a 60% reduction in other medical care including elective surgeries, routine outpatient care and lower ED visits. The six largest insurers reported $8.6…
Read MoreHospitals question viability and policy in OHS plans to share medical records
It’s unusual when independent consumer advocates and hospitals are on the same page. In a strongly worded letter, the CT Hospital Association laid out serious problems with OHS’s proposed plan to share data in their controversial Health Information Exchange (HIE). Only some hospitals were given the opportunity to comment on OHS’s plans. Under law, all…
Read MoreCT hospitals would fare better than most if all payers used Medicare payment rates
A new study published in Health Affairs finds that if commercial payment rates were set at fee-for-service Medicare levels in 2017, US hospital revenue (inpatient and outpatient) would drop by 35%. Interestingly, also raising Medicaid rates to Medicare levels does little to mitigate that, changing the revenue loss to 30%. However, the authors note that…
Read MoreProtecting affordability in a pandemic — Experts find fair prices for remdesivir between $10 and $4,500
In a nation hungry for good news in fighting the COVID-19 pandemic, remdesivir has emerged as a first ray of hope. The FDA has quickly approved the drug for emergency use with seriously ill patients. However there are concerns that the data supporting remdesivir’s effectiveness has not been published or peer reviewed by independent scientists…
Read More